(Q37257654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

1 reference

Andrea Jurisicova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Proteomics

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

551-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18761466%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

The myth of measurable disease in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Limitations to the use of the CA-125 antigen level in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Primary ovarian cancer chemotherapy: current standards of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Early events in the pathogenesis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

The biological impact of mass-spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Mass spectrometry-based proteomics: a useful tool for biomarker discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Mining the plasma proteome for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Immunoaffinity fractionation of plasma proteins by chicken IgY antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

The human plasma proteome: a nonredundant list developed by combination of four separate sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Importance of communication between producers and consumers of publicly available experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

New tumor markers: CA125 and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

High-resolution serum proteomic patterns for ovarian cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Mouse-based phenogenomics for modelling human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A mouse model for the molecular characterization of brca1-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Development of a syngeneic mouse model for events related to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Classification of cancer cell lines using an automated two-dimensional liquid mapping method with hierarchical clustering techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Classifications of ovarian cancer tissues by proteomic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A systems biology approach to the study of cisplatin drug resistance in ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Comparative proteome analysis of human epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Laser capture microdissection technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Automated laser capture microdissection for tissue proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Innovative proteomic approaches for cancer biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Serum proteomics profiling—a young technology begins to mature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Head-to-Head Comparison of Serum Fractionation Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Identification of specific reachable molecular targets in human breast cancer using a versatileex vivo proteomic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

A Chemical Proteomics Approach for the Identification of Accessible Antigens Expressed in Human Kidney Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551

Running before we can walk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.5.4.551